Atlanta, Georgia 30322

  • Traumatic Brain Injury


The purpose of this study is to determine if progesterone treatment safely reduces brain swelling and damage after injury.


Inclusion Criteria: - Blunt head trauma occuring within 11 hours - Ages 18 years and older (or Tanner Score of 5) - Index GCS between 4 and 12 Exclusion Criteria: - Spinal cord injury - Penetrating head trauma - Cardiopulmonary arrest upon ECC arrival - Status Epilepticus upon ECC arrival - Systolic BP < 90mmHG upon ECC arrival - Pulse Ox of < 90 (or pO2 < 60) - Prisoners or incarcerated individuals - Past Hx of significant intercranial pathology - Pregnant females - Blood alcohol level > 250 mg/dl - Non-English speakers (a Spanish version of the ICF is currently being developed) - Allergy(s) to soy, egg, or progesterone - Active breast or reproductive organ cancer(s) - Previous head injury or stroke within the past 6 weeks



Primary Contact:

Principal Investigator
Arthur L Kellermann, MD, MPH
Chairman - Emory University Dept. of Emergency Medicine

Backup Contact:


Location Contact:

Atlanta, Georgia 30322
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.